Works matching AU Mokhtare, Marjan


Results: 38
    1
    2
    3
    4

    The Incidence of Post-infectious Irritable Bowel Syndrome, Anxiety, and Depression in Iranian Patients with Coronavirus Disease 2019 Pandemic: A Cross-Sectional Study.

    Published in:
    Turkish Journal of Gastroenterology, 2022, v. 33, n. 12, p. 1033, doi. 10.5152/tjg.2022.21651
    By:
    • Farsi, Farnaz;
    • Zonooz, Sanaz Rezaei;
    • Ebrahimi, Zohreh;
    • Jebraili, Hanieh;
    • Morvaridi, Mehrnaz;
    • Azimi, Tahereh;
    • Sikaroudi, Masoumeh Khalighi;
    • Heshmati, Javad;
    • Khorrami, Soroush;
    • Mokhtare, Marjan;
    • Faghihi, Amirhossein;
    • Masoodi, Mohsen
    Publication type:
    Article
    5
    6
    7
    8

    Erratum to: SD1000: High Sustained Viral Response Rate in 1361 Patients With Hepatitis C Genotypes 1, 2, 3, and 4 Using a Low-cost Fixed-dose Combination Tablet of Generic Sofosbuvir and Daclatasvir: A Multicenter Phase III Clinical Trial.

    Published in:
    2021
    By:
    • Merat, Shahin;
    • Sharifi, Amir-Houshang;
    • Poustchi, Hossein;
    • Hajiani, Eskandar;
    • Gharavi, Abdolsamad;
    • Karimi, Jalal;
    • Mansour-Ghanaei, Fariborz;
    • Fattahi, Mohammad-Reza;
    • Ahmadi, Lida;
    • Somi, Mohammad-Hossein;
    • Kalantari, Hamid;
    • Ghadir, Mohammad-Reza;
    • Sheikhesmaeili, Farshad;
    • Baniasadi, Nadieh;
    • Sohrabi, Masoudreza;
    • Moosavy, Seyedhamid;
    • Ziaee, Masood;
    • Zahedi, Mohammad-Javad;
    • Mokhtare, Marjan;
    • Sali, Shahnaz
    Publication type:
    Correction Notice
    9
    10
    11
    12
    13
    14
    15

    The combination of sofosbuvir and daclatasvir is effective and safe in treating patients with hepatitis C and severe renal impairment.

    Published in:
    Journal of Gastroenterology & Hepatology, 2020, v. 35, n. 9, p. 1590, doi. 10.1111/jgh.14994
    By:
    • Poustchi, Hossein;
    • Majd Jabbari, Sara;
    • Merat, Shahin;
    • Sharifi, Amir‐Houshang;
    • Shayesteh, Ali Akbar;
    • Shayesteh, Elahe;
    • Minakari, Mohammad;
    • Fattahi, Mohammad Reza;
    • Moini, Maryam;
    • Roozbeh, Fatemeh;
    • Mansour‐Ghanaei, Fariborz;
    • Afshar, Behrooz;
    • Mokhtare, Marjan;
    • Amiriani, Taghi;
    • Sofian, Masoomeh;
    • Somi, Mohammad‐Hossein;
    • Agah, Shahram;
    • Maleki, Iradj;
    • Latifnia, Maryam;
    • Fattahi Abdizadeh, Mojtaba
    Publication type:
    Article
    16
    17

    Vitamin D3 Supplementation in Diarrhea-Predominant Irritable Bowel Syndrome Patients: The Effects on Symptoms Improvement, Serum Corticotropin-Releasing Hormone, and Interleukin-6 – A Randomized Clinical Trial.

    Published in:
    Complementary Medicine Research, 2020, v. 27, n. 5, p. 302, doi. 10.1159/000506149
    By:
    • Khalighi Sikaroudi, Masoumeh;
    • Mokhtare, Marjan;
    • Janani, Leila;
    • Faghihi Kashani, Amir Hossein;
    • Masoodi, Mohsen;
    • Agah, Shahram;
    • Abbaspour, Narjes;
    • Dehnad, Afsaneh;
    • Shidfar, Farzad
    Publication type:
    Article
    18
    19
    20
    21
    22
    23
    24
    25

    EFFECTS OF VITAMIN D3 SUPPLEMENTATION ON CLINICAL SYMPTOMS, QUALITY OF LIFE, SERUM SEROTONIN (5-HYDROXYTRYPTAMINE), 5-HYDROXY-INDOLE ACETIC ACID, AND RATIO OF 5-HIAA/5-HT IN PATIENTS WITH DIARRHEA-PREDOMINANT IRRITABLE BOWEL SYNDROME: A RANDOMIZED CLINICAL TRIAL.

    Published in:
    EXCLI Journal, 2020, v. 19, p. 652, doi. 10.17179/excli2020-2247
    By:
    • Sikaroudi, Masoumeh Khalighi;
    • Mokhtare, Marjan;
    • Shidfar, Farzad;
    • Janani, Leila;
    • Kashani, AmirHossein Faghihi;
    • Masoodi, Mohsen;
    • Agah, Shahram;
    • Dehnad, Afsaneh;
    • Shidfar, Shahrzad
    Publication type:
    Article
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38